10
Jul
2025

5AM-Founded Renasant Bio Secures $54.5M Seed for ADPKD Discovery

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

Small Molecules to Correct a Rare Kidney Disease: Emily Conley on The Long Run
5AM, OrbiMed Join $70M Bet on Prolynx Long-Lasting GLP-1 Weight Loss Medicines
From Structural Biology to Structuring Companies: Deb Palestrant on The Long Run
Dianthus Gets $100m to Take Complement Inhibition to a New Level